ÂÜÀòÂÒÂ×

Devang Shah is an accomplished scientific professional with extensive experience in pharmacology and pharmacokinetics. Currently serving as a Scientific Associate Director and Principal Scientist at Bristol Myers Squibb since October 2022, Devang previously held multiple positions at Syngene International Limited within the Biocon Bristol Myers Squibb research center from July 2010 to September 2022, including Lead Investigator and Senior Principal Investigator. Devang Shah earned a PhD (Tech) in Pharmacology/Pharmacokinetics from the Institute of Chemical Technology in March 2011, as well as an M.Pharm in Pharmacology from the same institution in 2006, and a Bachelor of Pharmacy from Padmashree Dr. D.Y. Patil College of Pharmacy in 2004.